Who has invested in Calluna Pharma?

Forbion, Sarsia, p53, Investinor are named among the investors backing Calluna Pharma.

Calluna Pharma Funding: $81M Raised, Series A (2024)

Calluna Pharma funding overview

Calluna Pharma has raised $81M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Calluna Pharma runs through 2024; nothing later has been disclosed. Investors on record include Forbion, Sarsia, p53, Investinor. 4 distinct backers are named across the disclosed rounds.

Calluna Pharma at a glance

Total raised: $81M
Latest round: Series A
Latest round date: January 2024
Notable investors: Forbion, Sarsia, p53, Investinor

Frequently asked about Calluna Pharma funding

How much has Calluna Pharma raised?: Calluna Pharma has raised $81M in total disclosed funding across the rounds on record.
Who has invested in Calluna Pharma?: Forbion, Sarsia, p53, Investinor are named among the investors backing Calluna Pharma.
What was the latest Calluna Pharma funding round?: The most recent disclosed round is a Series A, announced in January 2024.
Where is Calluna Pharma based?: No headquarters location is disclosed for Calluna Pharma.
When did Calluna Pharma last raise?: The last disclosed Calluna Pharma round closed in January 2024 at Series A.

Round data for Calluna Pharma is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Calluna Pharma Funding: $81M Raised, Series A (2024)

Calluna Pharma funding overview

Calluna Pharma at a glance

Frequently asked about Calluna Pharma funding

Companies related to Calluna Pharma (18)

Browse related funding lists (4)